M701

DRUG2 trials

Sponsors

Wuhan YZY Biopharma Co., Ltd.

Conditions

Malignant Ascites

Phase 2

Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

CompletedNCT06266091

Wuhan YZY Biopharma Co., Ltd.Malignant Ascites

Start: 2021-11-24End: 2024-08-01Updated: 2025-07-20

Phase 3

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Active, not recruitingNCT06432296

Wuhan YZY Biopharma Co., Ltd.Malignant Ascites

Start: 2024-03-20End: 2026-01-30Updated: 2025-07-20